Cargando…
AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings
Cervical cancer accounts for 21.7% of all cancer deaths in the sub-Saharan Africa with a case fatality rate of 68%. Nigeria’s Federal Ministry of Health has adopted cervical cancer screening (CCS) using visual inspection with acetic acid or Lugol’s iodine (VIA/VILI) and cryotherapy treatment for pre...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347443/ https://www.ncbi.nlm.nih.gov/pubmed/37433694 http://dx.doi.org/10.1136/bmjgh-2023-012311 |
_version_ | 1785073549161005056 |
---|---|
author | Ogunsola, Olabanjo Okunlola Olawepo, John Olajide Ajayi, Oluseye Osayi, Emmanuel Akinro, Yewande Toluwabori Ifechelobi, Chukwuemeka Chigbu, Chibuike Okonkwo, Prosper Ezeanolue, Echezona Edozie |
author_facet | Ogunsola, Olabanjo Okunlola Olawepo, John Olajide Ajayi, Oluseye Osayi, Emmanuel Akinro, Yewande Toluwabori Ifechelobi, Chukwuemeka Chigbu, Chibuike Okonkwo, Prosper Ezeanolue, Echezona Edozie |
author_sort | Ogunsola, Olabanjo Okunlola |
collection | PubMed |
description | Cervical cancer accounts for 21.7% of all cancer deaths in the sub-Saharan Africa with a case fatality rate of 68%. Nigeria’s Federal Ministry of Health has adopted cervical cancer screening (CCS) using visual inspection with acetic acid or Lugol’s iodine (VIA/VILI) and cryotherapy treatment for precancerous lesions as the preferred screening and treatment strategy. Using the Exploration, Preparation, Implementation and Sustainment Framework, our study documents our experience during the development, piloting and roll-out of the APIN Public Health Initiatives (APIN)-developed VIA Visual Application (AVIVA) for CCS using the VIA method in 86 APIN-supported health facilities across 7 states in Nigeria. Between December 2019 and June 2022, with the aid of 9 gynaecologists and 133 case finders, a total of 29 262 women living with HIV received VIA-based CCS and 1609 of them were VIA-positive, corresponding to VIA positivity rate of 5.5%. Over the 30 months duration and the 5 phases of CCS scale-up, AVIVA development and expansion, a total of 1247 cases were shared via the AVIVA App (3741 pictures), with 1058 of such cases undergoing expert review, corresponding to a reviewer rate of 84.8%. Overall, the use of the AVIVA App improved both the VIA-positive and VIA-negative concordance rates by 16 percentage points each (26%–42% and 80%–96%, respectively) from baseline to the end of the study. We concluded that the AVIVA App is an innovative tool to improve CCS rates and diagnostic precision by connecting health facility staff and expert reviewers in resource-limited settings. |
format | Online Article Text |
id | pubmed-10347443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-103474432023-07-15 AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings Ogunsola, Olabanjo Okunlola Olawepo, John Olajide Ajayi, Oluseye Osayi, Emmanuel Akinro, Yewande Toluwabori Ifechelobi, Chukwuemeka Chigbu, Chibuike Okonkwo, Prosper Ezeanolue, Echezona Edozie BMJ Glob Health Practice Cervical cancer accounts for 21.7% of all cancer deaths in the sub-Saharan Africa with a case fatality rate of 68%. Nigeria’s Federal Ministry of Health has adopted cervical cancer screening (CCS) using visual inspection with acetic acid or Lugol’s iodine (VIA/VILI) and cryotherapy treatment for precancerous lesions as the preferred screening and treatment strategy. Using the Exploration, Preparation, Implementation and Sustainment Framework, our study documents our experience during the development, piloting and roll-out of the APIN Public Health Initiatives (APIN)-developed VIA Visual Application (AVIVA) for CCS using the VIA method in 86 APIN-supported health facilities across 7 states in Nigeria. Between December 2019 and June 2022, with the aid of 9 gynaecologists and 133 case finders, a total of 29 262 women living with HIV received VIA-based CCS and 1609 of them were VIA-positive, corresponding to VIA positivity rate of 5.5%. Over the 30 months duration and the 5 phases of CCS scale-up, AVIVA development and expansion, a total of 1247 cases were shared via the AVIVA App (3741 pictures), with 1058 of such cases undergoing expert review, corresponding to a reviewer rate of 84.8%. Overall, the use of the AVIVA App improved both the VIA-positive and VIA-negative concordance rates by 16 percentage points each (26%–42% and 80%–96%, respectively) from baseline to the end of the study. We concluded that the AVIVA App is an innovative tool to improve CCS rates and diagnostic precision by connecting health facility staff and expert reviewers in resource-limited settings. BMJ Publishing Group 2023-07-11 /pmc/articles/PMC10347443/ /pubmed/37433694 http://dx.doi.org/10.1136/bmjgh-2023-012311 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Practice Ogunsola, Olabanjo Okunlola Olawepo, John Olajide Ajayi, Oluseye Osayi, Emmanuel Akinro, Yewande Toluwabori Ifechelobi, Chukwuemeka Chigbu, Chibuike Okonkwo, Prosper Ezeanolue, Echezona Edozie AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings |
title | AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings |
title_full | AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings |
title_fullStr | AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings |
title_full_unstemmed | AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings |
title_short | AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings |
title_sort | aviva: a telehealth tool to improve cervical cancer screening in resource-constrained settings |
topic | Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347443/ https://www.ncbi.nlm.nih.gov/pubmed/37433694 http://dx.doi.org/10.1136/bmjgh-2023-012311 |
work_keys_str_mv | AT ogunsolaolabanjookunlola avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings AT olawepojohnolajide avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings AT ajayioluseye avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings AT osayiemmanuel avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings AT akinroyewandetoluwabori avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings AT ifechelobichukwuemeka avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings AT chigbuchibuike avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings AT okonkwoprosper avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings AT ezeanolueechezonaedozie avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings |